A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RECOMBINANT HUMAN PLASMA GELSOLIN (RHU-PGSN) ADDED TO STANDARD OF CARE FOR TREATMENT OF SUBJECTS WITH SEVERE COVID-19 PNEUMONIA" CODIGO PROTOCOL BTI-2022020-002460-31


Tabla resumen
 Institución: URV Tipo: Transferencia
 Ámbito: Europeo Duración: 13/10/2020 - 14/10/2021
 Miembros: 4 IP: Mujer
 Fondos: 43893,90 Descripción: Europeo